In the BioHarmony Drug Report Database
Sodium zirconium cyclosilicate
Lokelma (sodium zirconium cyclosilicate) is a small molecule pharmaceutical. Sodium zirconium cyclosilicate was first approved as Lokelma on 2018-03-22. It is used to treat hyperkalemia in the USA. It has been approved in Europe to treat hyperkalemia. Lokelma’s patents are valid until 2035-10-14 (FDA).
Trade Name
|
Lokelma |
|---|---|
Common Name
|
sodium zirconium cyclosilicate |
ChEMBL ID
|
CHEMBL3301592 |
Indication
|
hyperkalemia |
Drug Class
|
Quaternary ammonium derivatives |
Image (chem structure or protein)